COR

AI Research

$1B US Distribution Investment Through 2030 + Q1 Revenue $85.9B (+5.5%) → Wells Fargo Raises PT to $429

Cencora committed to invest $1 billion through 2030 to expand its U.S. drug distribution network, including a new 530,000 square-foot national distribution center in Harrison, Ohio, expected operational by spring 2027, and expansions in Alabama and California. Fiscal Q1 2026 revenue of $85.9 billion grew 5.5% year-over-year, with adjusted diluted EPS of $4.08 rising 9.4%, and the company raised adjusted operating income guidance to +11.5% to +13.5% while completing the OneOncology acquisition. Wells Fargo raised its price target to $429 with an Overweight rating, 11 of 13 analysts rate the stock Buy, and a quarterly dividend of $0.60 per share was declared payable March 2, 2026.